{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:37:43Z","timestamp":1774330663907,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E26\/202.781\/2017"],"award-info":[{"award-number":["E26\/202.781\/2017"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302401\/2016-4"],"award-info":[{"award-number":["302401\/2016-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10620-019-5475-3","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T06:52:57Z","timestamp":1561013577000},"page":"1916-1922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil"],"prefix":"10.1007","volume":"64","author":[{"given":"Renata F.","family":"Amorim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo R. C.","family":"Viegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Jos\u00e9 V.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara C.","family":"Esberard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn S.","family":"Chinem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Ribeiro-Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3647-7324","authenticated-orcid":false,"given":"Heitor S.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Teresa P.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"5475_CR1","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med.. 2016;13:e1002152.","journal-title":"PLoS Med."},{"key":"5475_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","volume":"387","author":"K Dheda","year":"2016","unstructured":"Dheda K, Barry CE III, Maartens G. Tuberculosis. Lancet. 2016;387:1211\u20131226.","journal-title":"Lancet"},{"key":"5475_CR3","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/S2214-109X(14)70361-4","volume":"3","author":"A Zumla","year":"2015","unstructured":"Zumla A, George A, Sharma V, et al. The WHO 2014 global tuberculosis report\u2013further to go. Lancet Glob Health. 2015;3:e10\u201312.","journal-title":"Lancet Glob Health"},{"key":"5475_CR4","unstructured":"WHO. Global tuberculosis report 2017 World Health Organization. 2017; http:\/\/www.who.int\/tb\/data\/en\/ . Accessed 24 June 2018;147."},{"key":"5475_CR5","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1086\/314075","volume":"31","author":"D Menzies","year":"2000","unstructured":"Menzies D. What does tuberculin reactivity after bacille Calmette-Guerin vaccination tell us? Clin Infect Dis. 2000;31:S71\u201374.","journal-title":"Clin Infect Dis"},{"key":"5475_CR6","first-page":"1192","volume":"10","author":"M Farhat","year":"2006","unstructured":"Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192\u20131204.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5475_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/ecco-jcc\/jjx022","volume":"11","author":"C Taxonera","year":"2017","unstructured":"Taxonera C, Ponferrada A, Bermejo F, et al. Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory bowel disease. J Crohn\u2019s Colitis.. 2017;11:792\u2013800.","journal-title":"J Crohn\u2019s Colitis."},{"key":"5475_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","volume":"2","author":"WS Mow","year":"2004","unstructured":"Mow WS, Abreu-Martin MT, Papadakis KA, Pitchon HE, Targan SR, Vasiliauskas EA. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol Hepatol. 2004;2:309\u2013313.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5475_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"D Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340\u2013354.","journal-title":"Ann Intern Med"},{"key":"5475_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/IAI.64.1.16-22.1996","volume":"64","author":"M Harboe","year":"1996","unstructured":"Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 1996;64:16\u201322.","journal-title":"Infect Immun"},{"key":"5475_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.crohns.2011.09.011","volume":"6","author":"U Helwig","year":"2012","unstructured":"Helwig U, Muller M, Hedderich J, Schreiber S. Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients. J Crohn\u2019s Colitis.. 2012;6:419\u2013424.","journal-title":"J Crohn\u2019s Colitis."},{"key":"5475_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-2362.2011.02502.x","volume":"41","author":"P Papay","year":"2011","unstructured":"Papay P, Eser A, Winkler S, et al. Predictors of indeterminate IFN-gamma release assay in screening for latent TB in inflammatory bowel diseases. Eur J Clin Invest. 2011;41:1071\u20131076.","journal-title":"Eur J Clin Invest"},{"key":"5475_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1183\/09031936.00107608","volume":"33","author":"F Bartalesi","year":"2009","unstructured":"Bartalesi F, Vicidomini S, Goletti D, et al. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J.. 2009;33:586\u2013593.","journal-title":"Eur Respir J."},{"key":"5475_CR14","first-page":"21","volume":"22","author":"G Andrisani","year":"2013","unstructured":"Andrisani G, Armuzzi A, Papa A, et al. Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. J Gastrointest Liver Dis: JGLD.. 2013;22:21\u201325.","journal-title":"J Gastrointest Liver Dis: JGLD."},{"key":"5475_CR15","doi-asserted-by":"publisher","first-page":"e59546","DOI":"10.1371\/journal.pone.0059546","volume":"8","author":"RE Steffen","year":"2013","unstructured":"Steffen RE, Caetano R, Pinto M, et al. Cost-effectiveness of Quantiferon(R)-TB gold-in-tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil. PLoS One. 2013;8:e59546.","journal-title":"PLoS One"},{"key":"5475_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohn\u2019s Colitis.. 2017;11:649\u2013670.","journal-title":"J Crohn\u2019s Colitis."},{"key":"5475_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomollon","year":"2017","unstructured":"Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: Part 1: diagnosis and medical management. J Crohn\u2019s Colitis.. 2017;11:3\u201325.","journal-title":"J Crohn\u2019s Colitis."},{"key":"5475_CR18","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1164\/ajrccm.162.6.2004022","volume":"162","author":"SM Marks","year":"2000","unstructured":"Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000;162:2033\u20132038.","journal-title":"Am J Respir Crit Care Med"},{"key":"5475_CR19","doi-asserted-by":"publisher","first-page":"e1000381","DOI":"10.1371\/journal.pmed.1000381","volume":"7","author":"I Baussano","year":"2010","unstructured":"Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med.. 2010;7:e1000381.","journal-title":"PLoS Med."},{"key":"5475_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1164\/ajrccm.162.2.9910055","volume":"162","author":"AR Moss","year":"2000","unstructured":"Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless: a prospective study. Am J Respir Crit Care Med. 2000;162:460\u2013464.","journal-title":"Am J Respir Crit Care Med"},{"key":"5475_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","volume":"189","author":"SE Dorman","year":"2014","unstructured":"Dorman SE, Belknap R, Graviss EA, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014;189:77\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"5475_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749\u2013753.","journal-title":"Gut"},{"key":"5475_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.crohns.2012.05.012","volume":"7","author":"A Jauregui-Amezaga","year":"2013","unstructured":"Jauregui-Amezaga A, Turon F, Ordas I, et al. Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. J Crohn\u2019s Colitis.. 2013;7:208\u2013212.","journal-title":"J Crohn\u2019s Colitis."},{"key":"5475_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.crohns.2012.08.010","volume":"7","author":"K Greveson","year":"2013","unstructured":"Greveson K, Goodhand J, Capocci S, et al. Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNF alpha therapy. J Crohn\u2019s Colitis.. 2013;7:412\u2013418.","journal-title":"J Crohn\u2019s Colitis."},{"key":"5475_CR25","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/ibd.22901","volume":"18","author":"N Shahidi","year":"2012","unstructured":"Shahidi N, Fu YT, Qian H, Bressler B. Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18:2034\u20132042.","journal-title":"Inflamm Bowel Dis"},{"key":"5475_CR26","doi-asserted-by":"publisher","first-page":"e0198756","DOI":"10.1371\/journal.pone.0198756","volume":"13","author":"DH Jeong","year":"2018","unstructured":"Jeong DH, Kang J, Jung YJ, et al. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA. PLoS ONE. 2018;13:e0198756.","journal-title":"PLoS ONE"},{"key":"5475_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bjid.2013.05.008","volume":"18","author":"IP Cardoso","year":"2014","unstructured":"Cardoso IP, de Almeida NP, Gotardo DR, Cardeal M, Santana GO. Tuberculin skin testing in inflammatory bowel disease patients from an endemic area of Brazil. Braz J Infect Dis. 2014;18:60\u201364.","journal-title":"Braz J Infect Dis"},{"key":"5475_CR28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3109\/00365521.2015.1064470","volume":"50","author":"GJ Mantzaris","year":"2015","unstructured":"Mantzaris GJ, Tsironikos D, Tzanetakou X, et al. The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy. Scand J Gastroenterol. 2015;50:1451\u20131455.","journal-title":"Scand J Gastroenterol"},{"key":"5475_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ibd.21329","volume":"17","author":"BJ Qumseya","year":"2011","unstructured":"Qumseya BJ, Ananthakrishnan AN, Skaros S, et al. QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States. Inflamm Bowel Dis. 2011;17:77\u201383.","journal-title":"Inflamm Bowel Dis"},{"key":"5475_CR30","first-page":"776","volume":"35","author":"DP Leon de","year":"2008","unstructured":"de Leon DP, Acevedo-Vasquez E, Alvizuri S, et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol. 2008;35:776\u2013781.","journal-title":"J Rheumatol"},{"key":"5475_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/thoraxjnl-2013-203247","volume":"68","author":"I Abubakar","year":"2013","unstructured":"Abubakar I, Stagg HR, Whitworth H, Lalvani A. How should I interpret an interferon gamma release assay result for tuberculosis infection? Thorax. 2013;68:298\u2013301.","journal-title":"Thorax"},{"key":"5475_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40291-014-0125-0","volume":"19","author":"JR Campbell","year":"2015","unstructured":"Campbell JR, Krot J, Elwood K, Cook V, Marra F. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants. Mol Diagn Ther.. 2015;19:9\u201324.","journal-title":"Mol Diagn Ther."},{"key":"5475_CR33","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","volume":"27","author":"M Bocchino","year":"2008","unstructured":"Bocchino M, Matarese A, Bellofiore B, et al. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis. 2008;27:907\u2013913.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5475_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.dld.2013.03.005","volume":"45","author":"F Bermejo","year":"2013","unstructured":"Bermejo F, Algaba A, Chaparro M, et al. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study. Dig Liver Dis. 2013;45:733\u2013737.","journal-title":"Dig Liver Dis"},{"key":"5475_CR35","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/apt.12037","volume":"36","author":"P Papay","year":"2012","unstructured":"Papay P, Primas C, Eser A, et al. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-alpha inhibitors. Aliment Pharmacol Ther. 2012;36:858\u2013865.","journal-title":"Aliment Pharmacol Ther"},{"key":"5475_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/flgastro-2017-100951","volume":"9","author":"AA Thi","year":"2018","unstructured":"Thi AA, Abbara A, Bouri S, et al. Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study. Frontline Gastroenterol.. 2018;9:7.","journal-title":"Frontline Gastroenterol."},{"key":"5475_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12879-017-2301-4","volume":"17","author":"P Auguste","year":"2017","unstructured":"Auguste P, Tsertsvadze A, Pink J, et al. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 2017;17:200.","journal-title":"BMC Infect Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-5475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-5475-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-5475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T07:15:22Z","timestamp":1663744522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-5475-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["5475"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-5475-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}